168 related articles for article (PubMed ID: 10807663)
1. Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells.
Zhang H; Teng X; Snead C; Catravas JD
Br J Pharmacol; 2000 May; 130(2):270-8. PubMed ID: 10807663
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells.
Zhang H; Chen X; Teng X; Snead C; Catravas JD
Biochem Pharmacol; 1998 Jun; 55(11):1873-80. PubMed ID: 9714306
[TBL] [Abstract][Full Text] [Related]
3. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
4. A reverse nuclear factor-kappaB element in the rat type II nitric oxide synthase promoter mediates the induction by interleukin-1beta and interferon-gamma in rat aortic smooth muscle cells.
Teng X; Zhang H; Snead C; Catravas JD
Gen Pharmacol; 2000 Jan; 34(1):9-16. PubMed ID: 10793263
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y
Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279
[TBL] [Abstract][Full Text] [Related]
6. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
[TBL] [Abstract][Full Text] [Related]
8. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene.
Taylor BS; de Vera ME; Ganster RW; Wang Q; Shapiro RA; Morris SM; Billiar TR; Geller DA
J Biol Chem; 1998 Jun; 273(24):15148-56. PubMed ID: 9614127
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide differentially regulates induction of type II nitric oxide synthase in rat vascular smooth muscle cells versus macrophages.
Zhang H; Snead C; Catravas JD
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):529-35. PubMed ID: 11304468
[TBL] [Abstract][Full Text] [Related]
10. cAMP inhibits inducible nitric oxide synthase expression and NF-kappaB-binding activity in cultured rat hepatocytes.
Harbrecht BG; Taylor BS; Xu Z; Ramalakshmi S; Ganster RW; Geller DA
J Surg Res; 2001 Aug; 99(2):258-64. PubMed ID: 11469895
[TBL] [Abstract][Full Text] [Related]
11. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer.
Perrella MA; Pellacani A; Wiesel P; Chin MT; Foster LC; Ibanez M; Hsieh CM; Reeves R; Yet SF; Lee ME
J Biol Chem; 1999 Mar; 274(13):9045-52. PubMed ID: 10085153
[TBL] [Abstract][Full Text] [Related]
12. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages.
Vila-del Sol V; Díaz-Muñoz MD; Fresno M
J Leukoc Biol; 2007 Jan; 81(1):272-83. PubMed ID: 17035338
[TBL] [Abstract][Full Text] [Related]
13. Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.
Pingle SC; Sanchez JF; Hallam DM; Williamson AL; Maggirwar SB; Ramkumar V
Mol Pharmacol; 2003 Jun; 63(6):1238-47. PubMed ID: 12761333
[TBL] [Abstract][Full Text] [Related]
14. Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation.
Yan ZQ; Sirsjö A; Bochaton-Piallat ML; Gabbiani G; Hansson GK
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2854-62. PubMed ID: 10591661
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites.
Marks-Konczalik J; Chu SC; Moss J
J Biol Chem; 1998 Aug; 273(35):22201-8. PubMed ID: 9712833
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells.
Kolyada AY; Madias NE
Mol Med; 2001 May; 7(5):329-43. PubMed ID: 11474579
[TBL] [Abstract][Full Text] [Related]
17. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
Yu Z; Zhang W; Kone BC
Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells.
Teng X; Zhang H; Snead C; Catravas JD
Am J Physiol Cell Physiol; 2002 Jan; 282(1):C144-52. PubMed ID: 11742807
[TBL] [Abstract][Full Text] [Related]
19. Effects of mechanistically distinct NF-kappaB inhibitors on glial inducible nitric-oxide synthase expression.
Davis RL; Sanchez AC; Lindley DJ; Williams SC; Syapin PJ
Nitric Oxide; 2005 Jun; 12(4):200-9. PubMed ID: 15890551
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells.
Zhou J; Struthers AD; Lyles GA
Pharmacol Res; 1999 May; 39(5):363-73. PubMed ID: 10328994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
